 Nahed El-Hassan
Concepts (155)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypoglycemia | 5 | 2021 | 52 | 2.070 |
Why?
| | Infant, Newborn, Diseases | 4 | 2021 | 57 | 1.900 |
Why?
| | Infant, Premature, Diseases | 5 | 2018 | 94 | 1.900 |
Why?
| | Enterocolitis, Necrotizing | 3 | 2018 | 36 | 1.690 |
Why?
| | Hypoplastic Left Heart Syndrome | 5 | 2018 | 94 | 1.500 |
Why?
| | Gastroschisis | 2 | 2021 | 38 | 1.460 |
Why?
| | Infant, Newborn | 25 | 2024 | 2767 | 1.310 |
Why?
| | Educational Status | 5 | 2024 | 223 | 1.290 |
Why?
| | Premature Birth | 2 | 2022 | 148 | 1.230 |
Why?
| | Infant, Premature | 6 | 2021 | 318 | 1.090 |
Why?
| | Achievement | 2 | 2016 | 39 | 1.040 |
Why?
| | Blood Glucose | 4 | 2021 | 435 | 1.020 |
Why?
| | Esophageal Atresia | 1 | 2024 | 6 | 0.980 |
Why?
| | Tracheoesophageal Fistula | 1 | 2024 | 11 | 0.980 |
Why?
| | Palliative Care | 4 | 2018 | 186 | 0.900 |
Why?
| | Norwood Procedures | 3 | 2018 | 57 | 0.860 |
Why?
| | Conduct Disorder | 1 | 2022 | 9 | 0.820 |
Why?
| | Infant | 11 | 2024 | 3560 | 0.810 |
Why?
| | Female | 25 | 2024 | 26668 | 0.640 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2018 | 79 | 0.610 |
Why?
| | Gastrostomy | 1 | 2018 | 53 | 0.600 |
Why?
| | Diabetes Mellitus | 1 | 2021 | 285 | 0.590 |
Why?
| | Social Class | 1 | 2018 | 94 | 0.590 |
Why?
| | Arkansas | 5 | 2024 | 1962 | 0.580 |
Why?
| | Enteral Nutrition | 1 | 2018 | 147 | 0.580 |
Why?
| | Retrospective Studies | 13 | 2022 | 6172 | 0.570 |
Why?
| | Humans | 33 | 2024 | 50251 | 0.560 |
Why?
| | Mothers | 1 | 2018 | 256 | 0.510 |
Why?
| | Hypertelorism | 1 | 2015 | 4 | 0.500 |
Why?
| | Syndactyly | 1 | 2015 | 4 | 0.500 |
Why?
| | Toes | 1 | 2015 | 14 | 0.500 |
Why?
| | Food Additives | 1 | 2015 | 7 | 0.500 |
Why?
| | Anal Canal | 1 | 2015 | 21 | 0.500 |
Why?
| | Urogenital Abnormalities | 1 | 2015 | 17 | 0.500 |
Why?
| | Respiratory Syncytial Virus Infections | 2 | 2006 | 34 | 0.490 |
Why?
| | Polysaccharides, Bacterial | 1 | 2015 | 14 | 0.490 |
Why?
| | Ibuprofen | 1 | 2014 | 21 | 0.460 |
Why?
| | Indomethacin | 1 | 2014 | 38 | 0.460 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2014 | 39 | 0.450 |
Why?
| | Infant, Extremely Low Birth Weight | 1 | 2014 | 27 | 0.450 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2014 | 38 | 0.450 |
Why?
| | Male | 18 | 2024 | 25483 | 0.420 |
Why?
| | Antibodies, Monoclonal | 2 | 2006 | 461 | 0.380 |
Why?
| | Kidney | 1 | 2015 | 672 | 0.360 |
Why?
| | High-Frequency Ventilation | 2 | 2000 | 23 | 0.350 |
Why?
| | Child | 5 | 2024 | 6854 | 0.330 |
Why?
| | Risk Factors | 6 | 2020 | 3608 | 0.330 |
Why?
| | Heart Transplantation | 3 | 2018 | 342 | 0.330 |
Why?
| | Databases, Factual | 4 | 2022 | 655 | 0.320 |
Why?
| | Case-Control Studies | 3 | 2021 | 1132 | 0.310 |
Why?
| | Microphthalmos | 1 | 2007 | 7 | 0.300 |
Why?
| | Lip | 1 | 2007 | 11 | 0.300 |
Why?
| | Antiviral Agents | 2 | 2006 | 170 | 0.300 |
Why?
| | Mandible | 1 | 2007 | 21 | 0.300 |
Why?
| | Phosphates | 1 | 2007 | 47 | 0.290 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2007 | 47 | 0.280 |
Why?
| | Decision Support Techniques | 1 | 2006 | 71 | 0.270 |
Why?
| | Diagnosis, Differential | 3 | 2018 | 1043 | 0.260 |
Why?
| | Intensive Care Units, Neonatal | 2 | 2023 | 116 | 0.250 |
Why?
| | Cohort Studies | 4 | 2018 | 1397 | 0.250 |
Why?
| | Hospitalization | 4 | 2017 | 663 | 0.240 |
Why?
| | Antibiotic Prophylaxis | 1 | 2004 | 61 | 0.220 |
Why?
| | Vancomycin | 1 | 2004 | 81 | 0.220 |
Why?
| | Bacterial Infections | 1 | 2004 | 95 | 0.220 |
Why?
| | Cross Infection | 1 | 2004 | 92 | 0.220 |
Why?
| | Birth Weight | 2 | 2018 | 120 | 0.220 |
Why?
| | Catheterization, Central Venous | 1 | 2004 | 84 | 0.210 |
Why?
| | Asthma | 1 | 2006 | 279 | 0.210 |
Why?
| | Glucose | 2 | 2021 | 339 | 0.210 |
Why?
| | Pregnancy | 2 | 2021 | 2605 | 0.210 |
Why?
| | Length of Stay | 3 | 2018 | 627 | 0.200 |
Why?
| | Immunocompetence | 1 | 2002 | 18 | 0.200 |
Why?
| | Pericarditis | 1 | 2002 | 20 | 0.200 |
Why?
| | Mucus | 1 | 2001 | 4 | 0.200 |
Why?
| | Pseudomonas Infections | 1 | 2002 | 49 | 0.200 |
Why?
| | Pulmonary Atelectasis | 1 | 2001 | 12 | 0.200 |
Why?
| | Expectorants | 1 | 2001 | 14 | 0.200 |
Why?
| | Pseudomonas aeruginosa | 1 | 2002 | 73 | 0.190 |
Why?
| | Deoxyribonuclease I | 1 | 2001 | 34 | 0.190 |
Why?
| | Genomics | 1 | 2023 | 287 | 0.190 |
Why?
| | Airway Obstruction | 1 | 2001 | 47 | 0.190 |
Why?
| | Anti-Bacterial Agents | 2 | 2004 | 745 | 0.190 |
Why?
| | Birth Certificates | 1 | 2020 | 20 | 0.180 |
Why?
| | Anxiety | 1 | 2022 | 277 | 0.170 |
Why?
| | Recombinant Proteins | 1 | 2001 | 489 | 0.170 |
Why?
| | Gestational Age | 3 | 2021 | 419 | 0.170 |
Why?
| | Hospital Mortality | 2 | 2018 | 407 | 0.160 |
Why?
| | Radiography, Abdominal | 1 | 2018 | 27 | 0.160 |
Why?
| | Laparotomy | 1 | 2018 | 35 | 0.160 |
Why?
| | Ultrasonography, Doppler | 1 | 2018 | 42 | 0.160 |
Why?
| | Mathematics | 1 | 2018 | 45 | 0.150 |
Why?
| | Survival Rate | 2 | 2018 | 902 | 0.150 |
Why?
| | Respiratory Distress Syndrome, Newborn | 2 | 2014 | 52 | 0.150 |
Why?
| | Infant Mortality | 1 | 2018 | 60 | 0.150 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 559 | 0.140 |
Why?
| | Chromosome Disorders | 1 | 2017 | 35 | 0.140 |
Why?
| | Heart Bypass, Right | 1 | 2017 | 7 | 0.140 |
Why?
| | Depression | 1 | 2022 | 568 | 0.140 |
Why?
| | Prevalence | 1 | 2020 | 953 | 0.140 |
Why?
| | Models, Statistical | 1 | 2018 | 224 | 0.140 |
Why?
| | Neonatal Screening | 1 | 2016 | 47 | 0.130 |
Why?
| | Tracheostomy | 1 | 2016 | 71 | 0.130 |
Why?
| | Follow-Up Studies | 2 | 2018 | 2180 | 0.130 |
Why?
| | Treatment Outcome | 5 | 2017 | 5186 | 0.130 |
Why?
| | Child, Preschool | 2 | 2021 | 3877 | 0.120 |
Why?
| | Adult | 2 | 2021 | 13384 | 0.110 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2006 | 225 | 0.110 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 1169 | 0.110 |
Why?
| | Regression Analysis | 1 | 2014 | 393 | 0.110 |
Why?
| | Logistic Models | 1 | 2015 | 891 | 0.110 |
Why?
| | United States | 2 | 2023 | 4887 | 0.100 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2014 | 289 | 0.090 |
Why?
| | Adolescent | 1 | 2022 | 6402 | 0.090 |
Why?
| | Mitochondrial Proton-Translocating ATPases | 1 | 2009 | 4 | 0.080 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2009 | 29 | 0.080 |
Why?
| | Young Adult | 1 | 2018 | 4002 | 0.080 |
Why?
| | Orbital Implants | 1 | 2007 | 4 | 0.080 |
Why?
| | Twins | 1 | 2007 | 33 | 0.080 |
Why?
| | Optic Nerve | 1 | 2007 | 50 | 0.070 |
Why?
| | Reference Values | 1 | 2007 | 309 | 0.070 |
Why?
| | Quality-Adjusted Life Years | 1 | 2006 | 63 | 0.070 |
Why?
| | Aortic Valve | 1 | 2007 | 110 | 0.070 |
Why?
| | Cost of Illness | 1 | 2006 | 117 | 0.070 |
Why?
| | Risk Assessment | 2 | 2016 | 1257 | 0.070 |
Why?
| | Cost-Benefit Analysis | 1 | 2006 | 271 | 0.060 |
Why?
| | Comorbidity | 1 | 2006 | 606 | 0.060 |
Why?
| | Intensive Care, Neonatal | 1 | 2004 | 23 | 0.060 |
Why?
| | Primary Prevention | 1 | 2003 | 44 | 0.060 |
Why?
| | Dietary Supplements | 1 | 2007 | 437 | 0.060 |
Why?
| | Canada | 1 | 2023 | 101 | 0.050 |
Why?
| | Mutation | 1 | 2009 | 1296 | 0.050 |
Why?
| | Drug Administration Schedule | 1 | 2003 | 374 | 0.050 |
Why?
| | Genetic Testing | 1 | 2023 | 118 | 0.050 |
Why?
| | Administration, Inhalation | 1 | 2001 | 108 | 0.050 |
Why?
| | Radiography, Thoracic | 1 | 2001 | 65 | 0.050 |
Why?
| | Practice Guidelines as Topic | 1 | 2003 | 452 | 0.050 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 2000 | 9 | 0.040 |
Why?
| | Health Services Accessibility | 1 | 2023 | 408 | 0.040 |
Why?
| | Cardiac Surgical Procedures | 1 | 2002 | 295 | 0.040 |
Why?
| | Algorithms | 1 | 2021 | 618 | 0.040 |
Why?
| | Term Birth | 1 | 2016 | 16 | 0.040 |
Why?
| | Feeding Methods | 1 | 2016 | 15 | 0.030 |
Why?
| | Bottle Feeding | 1 | 2016 | 34 | 0.030 |
Why?
| | Linear Models | 1 | 2016 | 276 | 0.030 |
Why?
| | Chromosome Aberrations | 1 | 2017 | 297 | 0.030 |
Why?
| | Survival Analysis | 1 | 2017 | 666 | 0.030 |
Why?
| | Patient Selection | 1 | 2016 | 252 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2016 | 578 | 0.030 |
Why?
| | Health Status | 1 | 2016 | 296 | 0.030 |
Why?
| | Breast Feeding | 1 | 2016 | 190 | 0.030 |
Why?
| | Registries | 1 | 2014 | 513 | 0.020 |
Why?
| | Time Factors | 1 | 2016 | 2911 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2009 | 176 | 0.020 |
Why?
| | Base Sequence | 1 | 2009 | 644 | 0.020 |
Why?
| | Animals | 1 | 2000 | 13285 | 0.020 |
Why?
|
|
El-Hassan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|